Extremely potent human monoclonal antibodies from COVID-19 convalescent patients

Human monoclonal antibodies are safe, preventive, and therapeutic tools that can be rapidly developed to help restore the massive health and economic disruption caused by the coronavirus disease 2019 (COVID-19) pandemic. By single-cell sorting 4,277 SARS-CoV-2 spike protein-specific memory B cells f...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cell
Hauptverfasser: Andreano, Emanuele, Nicastri, Emanuele, Paciello, Ida, Pileri, Piero, Manganaro, Noemi, Piccini, Giulia, Manenti, Alessandro, Pantano, Elisa, Kabanova, Anna, Troisi, Marco, Vacca, Fabiola, Cardamone, Dario, De Santi, Concetta, Torres, Jonathan L., Ozorowski, Gabriel, Benincasa, Linda, Jang, Hyesun, Di Genova, Cecilia, Depau, Lorenzo, Brunetti, Jlenia, Agrati, Chiara, Capobianchi, Maria Rosaria, Castilletti, Concetta, Emiliozzi, Arianna, Fabbiani, Massimiliano, Montagnani, Francesca, Bracci, Luisa, Sautto, Giuseppe, Ross, Ted M., Montomoli, Emanuele, Temperton, Nigel, Ward, Andrew B., Sala, Claudia, Ippolito, Giuseppe, Rappuoli, Rino
Format: Artigo
Sprache:Inglês
Veröffentlicht: Elsevier Inc. 2021
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7901298/
https://ncbi.nlm.nih.gov/pubmed/33667349
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cell.2021.02.035
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge